Delivering intensive online care for people with chronic health conditions
Chronic pain, fatigue and complex health problems can interfere with participation in work. People seeking help may have already tried several treatments without the results they wanted, while facing overlapping symptoms and other challenges linked to their medical history.
SafeChoice Clinic & Research delivers tailored online treatment through multidisciplinary clinical teams. Intensive contact and close follow-up aim to improve patients' daily functioning and participation in work.
What stands out about SafeChoice Clinic & Research
Agenda Vestlandet awarded NOK 11.8 million to support SafeChoice training, scaling and continued research in 2025.
Frende Forsikring purchased SafeChoice treatment for customers in a return-to-work pilot reported by NRK in January 2025.
Co-founder Eirik Søfteland is an internal medicine and endocrinology specialist with over 20 years of clinical experience.
Co-founder Gerd Kvale is a clinical psychology professor with about 170 peer-reviewed papers and research on concentrated care.
SafeChoice is part of Eitri, the Bergen medical innovation centre; VIS places the company's team in its innovation incubator.
Gerd Kvale jointly won the Research Council of Norway's 2022 Innovation Award for the earlier Bergen 4-Day Treatment programme.
SafeChoice collaborates with Western Norway University of Applied Sciences and Uppsala University on research and development.
SafeChoice reports a collaboration with Helsinki University Hospital, described in its 2025 VIS incubator interview.
Gerd Kvale is a specialist in clinical psychology and clinical geropsychology who co-developed concentrated treatment approaches.
Eirik Søfteland earned his PhD in 2014, held a University of Bergen academic post and has published over 50 peer-reviewed papers.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.